750 related articles for article (PubMed ID: 15846285)
1. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
Le Blanc K; Ringdén O
Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by mesenchymal stem cells and clinical experience.
Le Blanc K; Ringdén O
J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.
Le Blanc K; Ringdén O
Curr Opin Immunol; 2006 Oct; 18(5):586-91. PubMed ID: 16879957
[TBL] [Abstract][Full Text] [Related]
4. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
10. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation.
Maitra B; Szekely E; Gjini K; Laughlin MJ; Dennis J; Haynesworth SE; Koç ON
Bone Marrow Transplant; 2004 Mar; 33(6):597-604. PubMed ID: 14716336
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
Wan CD; Cheng R; Wang HB; Liu T
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
Jones BJ; McTaggart SJ
Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome.
Chapel A; Bertho JM; Bensidhoum M; Fouillard L; Young RG; Frick J; Demarquay C; Cuvelier F; Mathieu E; Trompier F; Dudoignon N; Germain C; Mazurier C; Aigueperse J; Borneman J; Gorin NC; Gourmelon P; Thierry D
J Gene Med; 2003 Dec; 5(12):1028-38. PubMed ID: 14661178
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells and their potential as cardiac therapeutics.
Pittenger MF; Martin BJ
Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy by allogeneic stem cell transplantation.
Ringdén O
Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
[TBL] [Abstract][Full Text] [Related]
19. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F
Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377
[TBL] [Abstract][Full Text] [Related]
20. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells.
Li C; Zhang W; Jiang X; Mao N
Cell Tissue Res; 2007 Dec; 330(3):437-46. PubMed ID: 17899199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
